Jump to content

Examine individual changes

This page allows you to examine the variables generated by the Edit Filter for an individual change.

Variables generated for this change

VariableValue
Whether or not the edit is marked as minor (no longer in use) (minor_edit)
false
Name of the user account (user_name)
'2405:204:411D:297B:8831:6BED:D7CE:5794'
Whether or not a user is editing through the mobile interface (user_mobile)
true
Page ID (page_id)
905555
Page namespace (page_namespace)
0
Page title without namespace (page_title)
'Antiserum'
Full page title (page_prefixedtitle)
'Antiserum'
Action (action)
'edit'
Edit summary/reason (summary)
''
Old content model (old_content_model)
'wikitext'
New content model (new_content_model)
'wikitext'
Old page wikitext, before the edit (old_wikitext)
'{{about|the applications of antiserum|an explanation of its production|polyclonal antibodies}} '''Antiserum''' (plural: antisera) is human or nonhuman [[blood serum]] containing [[polyclonal response|polyclonal]] [[antibodies]] and is used to pass on [[passive immunity]] to many diseases. For example, passive antibody transfusion from a previous human survivor (convalescent serum) used to be the only known effective treatment for [[Ebola]] infection (but with little success rate).<ref>{{cite journal|last1=Mupapa|first1=K|last2=Massamba|first2=M|last3=Kibadi|first3=K|last4=Kuvula|first4=K|last5=Bwaka|first5=A|last6=Kipasa|first6=M|last7=Colebunders|first7=R|last8=Muyembe-Tamfum|first8=JJ|title=Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent Patients (suppl 1)|journal=The Journal of Infectious Diseases|date=1999|issue=Volume 179|pages=S18-S23|doi=10.1086/514298|url=http://jid.oxfordjournals.org/content/179/Supplement_1/S18.full?sid=b139b993-6946-4bf7-a999-9fc837193bda|accessdate=6 August 2014|pmid=9988160|volume=179 Suppl 1}}</ref> Antisera are widely used in diagnostic [[virology]] laboratories. The most common use of antiserum in humans is as [[antitoxin]] or [[antivenom]], to treat [[envenomation]]. ==How it works== {{ course assignment | course = Education Program:Louisiana State University/ENGL 2000: English Composition (Spring 2015) | term = 2015 Q1 }} Antibodies in the antiserum bind the infectious agent or [[antigen]].<ref>de Andrade, Fábio Goulart, et al. "The Production And Characterization Of Anti-Bothropic And Anti-Crotalic Igy Antibodies In Laying Hens: A Long Term Experiment." Toxicon 66.(2013): 18-24. Academic Search Complete. Web. 12 Feb. 2015.</ref> The [[immune system]] then recognizes foreign agents bound to antibodies and triggers a more robust [[immune response]]. The use of antiserum is particularly effective against pathogens which are capable of evading the immune system in the unstimulated state but which are not robust enough to evade the stimulated immune system. The existence of antibodies to the agent therefore depends on an initial "lucky survivor" whose immune system by chance discovered a counteragent to the pathogen, or a "host species" which carries the pathogen, but does not suffer from its effects.<ref>Mortimer, Nathan T., et al. "Parasitoid Wasp Venom SERCA Regulates Drosophila Calcium Levels And Inhibits Cellular Immunity." Proceedings Of The National Academy Of Sciences Of The United States Of America 110.23 (n.d.): 9427-9432. Biological Abstracts 1969 - Present. Web. 12 Feb. 2015.</ref> Further stocks of antiserum can then be produced from the initial donor or from a donor organism that is inoculated with the pathogen and cured by some stock of preexisting antiserum. Diluted snake venom is often used as an antiserum to give a passive immunity to the snake bite itself.<ref>O'Leary, M.A., K. Maduwage, and G.K. Isbister. "Use Of Immunoturbidimetry To Detect Venom–Antivenom Binding Using Snake Venoms." Journal of Pharmacological & Toxicological Methods 67.3 (2013): 177-181. Academic Search Complete. Web. 12 Feb. 2015.</ref><ref>Vogel, Carl-Wilhelm, Paul W. Finnegan, and David C. Fritzinger. "Humanized Cobra Venom Factor: Structure, Activity, And Therapeutic Efficacy In Preclinical Disease Models." Molecular Immunology 61.2 (2014): 191-203. Academic Search Complete. Web. 12 Feb. 2015.</ref> ==References== {{reflist}} ==External links== * {{MeshName|Antisera}} {{Immune sera and immunoglobulins}} {{Authority control}} [[Category:Blood]] {{immunology-stub}}'
New page wikitext, after the edit (new_wikitext)
'{{about|the applications of antiserum|an explanation of its production|polyclonal antibodies}} '''Antiserum''' (plural: antisera) is human or nonhuman [[blood serum]] containing [[polyclonal response|polyclonal]] [[antibodies]] and is used to pass on [[passive immunity]] to many diseases. For example, passive antibody transfusion from a previous human survivor (convalescent serum) used to be the only known effective treatment for [[Ebola]] infection (but with little success rate).<ref>{{cite journal|last1=Mupapa|first1=K|last2=Massamba|first2=M|last3=Kibadi|first3=K|last4=Kuvula|first4=K|last5=Bwaka|first5=A|last6=Kipasa|first6=M|last7=Colebunders|first7=R|last8=Muyembe-Tamfum|first8=JJ|title=Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent Patients (suppl 1)|journal=The Journal of Infectious Diseases|date=1999|issue=Volume 179|pages=S18-S23|doi=10.1086/514298|url=http://jid.oxfordjournals.org/content/179/Supplement_1/S18.full?sid=b139b993-6946-4bf7-a999-9fc837193bda|accessdate=6 August 2014|pmid=9988160|volume=179 Suppl 1}}</ref> Antisera are widely used in diagnostic [[virology]] laboratories. The most common use of antiserum in humans is as [[antitoxin]] or [[antivenom]], to treat [[envenomation]]. ==How it works== {{ course assignment | course = Education Program:Louisiana State University/ENGL 2000: English Composition (Spring 2015) | term = 2015 Q1 }} Antibodies in the antiserum bind the infectious agent or [[antigen]].<ref>de Andrade, Fábio Goulart, et al. "The Production And Characterization Of Anti-Bothropic And Anti-Crotalic Igy Antibodies In Laying Hens: A Long Term Experiment." Toxicon 66.(2013): 18-24. Academic Search Complete. Web. 12 Feb. 2015.</ref> The [[immune system]] then recognizes foreign agents bound to antibodies and triggers a more robust [[immune response]]. The use of antiserum is particularly effective against pathogens which are capable of evading the immune system in the unstimulated state but which are not robust enough to evade the stimulated immune system. The existence of antibodies to the agent therefore depends on an initial "lucky survivor" whose immune system by chance discovered a counteragent to the pathogen, or a "host species" which carries the pathogen, but does not suffer from its effects.<ref>Mortimer, Nathan T., et al. "Parasitoid Wasp Venom SERCA Regulates Drosophila Calcium Levels And Inhibits Cellular Immunity." Proceedings Of The National Academy Of Sciences Of The United States Of America 110.23 (n.d.): 9427-9432. Biological Abstracts 1969 - Present. Web. 12 Feb. 2015.</ref> Further stocks of antiserum can then be produced from the initial donor or from a donor organism that is inoculated with the pathogen and cured by some stock of preexisting antiserum. Diluted snake venom is often used as an antiserum to give a passive immunity to the snake bite itself.<ref>O'Leary, M.A., K. Maduwage, and G.K. Isbister. "Use Of Immunoturbidimetry To Detect Venom–Antivenom Binding Using Snake Venoms." Journal of Pharmacological & Toxicological Methods 67.3 (2013): 177-181. Academic Search Complete. Web. 12 Feb. 2015.</ref><ref>Vogel, Carl-Wilhelm, Paul W. Finnegan, and David C. Fritzinger. "Humanized Cobra Venom Factor: Structure, Activity, And Therapeutic Efficacy In Preclinical Disease Models." Molecular Immunology 61.2 (2014): 191-203. Academic Search Complete. Web. 12 Feb. 2015.</ref> ==References== 1.MUKUND PODDAR {{reflist}} ==External links== * {{MeshName|Antisera}} {{Immune sera and immunoglobulins}} {{Authority control}} [[Category:Blood]] {{immunology-stub}}'
Whether or not the change was made through a Tor exit node (tor_exit_node)
0
Unix timestamp of change (timestamp)
1519601695